Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 191

The DOI matches its OpenAlex record.

Canadian Headache Society Guideline: Acute Drug Therapy for Migraine Headache

Open access
Irene Worthington, Tamara Milka Pringsheim, Marek J Gawel, Jonathan P. Gladstone, Paul E. Cooper, Esma Dilli, Michel Aube, Élizabeth Leroux, Werner J. Becker, Canadian Headache Society Acute Migraine Treatment Guideline Development Group·2013·Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques

Abstract

OBJECTIVES: The primary objective of this guideline is to assist the practitioner in choosing an appropriate acute medication for an individual with migraine, based on current evidence in the medical literature and expert consensus. It is focused on patients with episodic migraine ( headache on ≤ 14 days a month). METHODS: A detailed search strategy was used to find a relevant meta-analyses, systematic reviews and randomized double-blind controlled trials. Recommendations were graded with the Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group, using a consensus group. In addition, a general literature review and expert consensus were used for aspects of acute therapy for which randomized controlled trials were not available. RESULTS: Twelve acute medications received a strong recommendation for use in acute migraine therapy (almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, sumatriptan, zomitriptan, ASA, ibuprofen, naproxen sodium, diclofenac potassium, and acetaminophen). Four received a weak recommendation for use (dihydroergotamine, ergotamine, codeine-containing combination analgesics, and tramadol- containing medications). Three of these were NOT recommended for routine use (ergotamine and codeine- and tramadol- containing medications). Strong recommendations were made to avoid use of butorphanol and butalbital- containing medications. Metoclopramide and domperidone were strongly recommended for use when necessary. Our analysis also resulted in the formulation of eight general acute migraine management strategies. These were grouped into: 1) two mild-moderate attack strategies, 2) two moderate-severe attack or NSAID failure strategies, 3) three refractory migraine strategies, and 4) a vasoconstrictor unresponsive-contraindicated strategy. Additional were developed for menstrual migraine during pregnancy, and migraine during lactation. CONCLUSION: This guideline provides evidence-based advice on acute pharmacological migraine therapy, and should be helpful to both health professionals and patients, The available medications have been organized into a series of strategies based on patient clinical features. These strategies may help practitioners make appropriate acute medication choices for patients with migraine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

OpenAlex · 10.1017/s0317167100017819

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 191

Metadata

Authors
Worthington, I., Pringsheim, T. M., Gawel, M. J., Gladstone, J. P., Cooper, P. E., Dilli, E., Aube, M., Leroux, É., Becker, W. J., & Canadian Headache Society Acute Migraine Treatment Guideline Development Group
Venue
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
Publisher
Cambridge University Press
Published
2013-09-01
Volume
40
Issue
S3
Pages
S1-S3
ISSN
0317-1671 (ISSN-L)
OpenAlex
W2128758183
Cited by
191
References
0
FWCI
8.29
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Canadian Headache Society Guideline: Acute Drug Therapy for Migraine Headache. https://app.cochat.ai/papers/10.1017/s0317167100017819
The paper
Worthington, I., Pringsheim, T. M., Gawel, M. J., Gladstone, J. P., Cooper, P. E., Dilli, E., Aube, M., Leroux, É., Becker, W. J., & Canadian Headache Society Acute Migraine Treatment Guideline Development Group. (2013). Canadian Headache Society Guideline: Acute Drug Therapy for Migraine Headache. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. https://doi.org/10.1017/s0317167100017819

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.